Nuzenio

Amtagvi

Amtagvi news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 11 publisher sources 100/100 entity strength

Latest news

IOVA Q2 Earnings Beat, Stock Jumps 43% on Strong Amtagvi Uptake - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:52:00 GMTIovance Biotherapeutics Inc (IOVA) (Q2 2026) Earnings Call Highl - GuruFocusGuruFocus · Fri, 07 Aug 2026 00:34:12 GMTIovance Biotherapeutics Q2 Earnings Call Highlights - MarketBeatMarketBeat · Thu, 06 Aug 2026 21:01:37 GMTUPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 20:41:48 GMTBiotech Analysis Central Model 10+ Portfolio #4 Iovance Biotherapeutics; AMTAGVI Revenue Growth 66% YoY, Q4 2026 Lifileucel NSCLC Data Updates, UPS And DDLPS Presentation Oct 2026, And Catalysts (NASDAQ:IOVA) - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 18:35:49 GMTIovance - Stock Soars On Q2 Earnings - Critical Data In Melanoma, NSCLC Due September - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 18:14:27 GMTIovance shares surge 39% as Amtagvi Q2 revenue and margins surpass expectations - TechStock²TechStock² · Thu, 06 Aug 2026 16:10:29 GMTIovance Biotherapeutics Reports Record Q2 Revenue and Reviews 2026 Outlook on Strong Amtagvi Demand - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 14:54:49 GMT

Timeline

Fri, 07 Aug 2026 13:52:00 GMTIOVA Q2 Earnings Beat, Stock Jumps 43% on Strong Amtagvi Uptake - Yahoo Finance
Fri, 07 Aug 2026 00:34:12 GMTIovance Biotherapeutics Inc (IOVA) (Q2 2026) Earnings Call Highl - GuruFocus
Thu, 06 Aug 2026 21:01:37 GMTIovance Biotherapeutics Q2 Earnings Call Highlights - MarketBeat
Thu, 06 Aug 2026 20:41:48 GMTUPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle - Fierce Pharma
Thu, 06 Aug 2026 18:35:49 GMTBiotech Analysis Central Model 10+ Portfolio #4 Iovance Biotherapeutics; AMTAGVI Revenue Growth 66% YoY, Q4 2026 Lifileucel NSCLC Data Updates, UPS And DDLPS Presentation Oct 2026, And Catalysts (NASDAQ:IOVA) - Seeking Alpha
Thu, 06 Aug 2026 18:14:27 GMTIovance - Stock Soars On Q2 Earnings - Critical Data In Melanoma, NSCLC Due September - Seeking Alpha

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Amtagvi.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.